As previously reported, on January 11, the Canadian Agency for Drugs and Technologies in Health (CADTH) posted a discussion paper regarding the proposed framework for a potential pan-Canadian formulary. The pan-Canadian Advisory Panel has posted further information, including respondent feedback and focus group feedback. The Final Report: Building Toward a Potential Pan-Canadian Formulary was released in June, together with summary highlights.
Highlights of the Panel’s recommendations are:
- Six principles for the formulary: universal and integrated; equitable; effective, safe, and high quality; sustainable; efficient and timely; and inclusive, transparent, with fair process.
- A potential pan-Canadian formulary should:
- be a dynamic and living system that involves multiple perspectives
- be aligned with, if not integrated into, other elements of the health system
- be equitable and support a distinction-based approach that promotes self-determination
- incorporate evidence that considers diverse populations, perspectives, and experiences
- be aligned with current evidence
- be sustainable
- adopt systems and process efficiencies, including (i) providing simplified points of access for related products and (ii) exploring a hybrid submission review model.
- Take a staged approach to develop a potential pan-Canadian formulary.
- Build public trust through transparent decision-making.
- Ensure accountability and reason-driven decision-making.
[View source.]